Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema
暂无分享,去创建一个
M. Gillies | I. McAllister | S. Wickremasinghe | L. Lim | H. Mehta | E. Cornish | Vuong Nguyen | S. Fraser-Bell | K. Teo | V. Nguyen